3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Lymphoma, Follicular
3
Lymphoma
3
Lymphoma, Non-Hodgkin
2
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Multiple Myeloma
1
Melanoma
1
Lymphoproliferative Disorders
1
Lymphomatoid Granulomatosis
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Kidney Neoplasms
1
Influenza, Human
1
Epstein-Barr Virus Infections
1
Breast Neoplasms
1
Blast Crisis
1
Interventions
Cyclophosphamide
58
Peripheral Blood Stem Cell Transplantation
48
fludarabine phosphate
44
Busulfan
38
Tacrolimus
35
Methotrexate
32
Mycophenolic Acid
31
Antilymphocyte Serum
29
Cyclosporine
28
Filgrastim
27
Whole-Body Irradiation
25
Radiotherapy
23
Etoposide
19
Cytarabine
19
Methylprednisolone
18
Melphalan
17
Cord Blood Stem Cell Transplantation
17
Flow Cytometry
13
Thiotepa
10
Therapeutics
10
Sirolimus
9
Dasatinib
9
merphos
8
Psychiatric Rehabilitation
8
Prednisone
8
Imatinib Mesylate
8
Carboplatin
8
sargramostim
7
fludarabine
7
Vorinostat
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Blast Crisis
×
Interferons
×
Lymphoid
×
Clear all
NCT00763763
2011-10-05
AFR07
Assistance Publique - Hôpitaux de Paris
Phase 2
Completed
55 enrolled